Head Topics

Endo stock rises 6% after Q3 beats and upbeat 2018 guidance

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Endo International PLC shares rose 6% in Thursday premarket trade after the company reported third-quarter adjusted profit and revenue beats and upbeat 2018 guidance. The company reported a net loss of $173.2 million, or a loss of 77 cents per share, after a loss of $96.7 million, or a loss of 43 cents per share in the year-earlier period. Endo said its adjusted earnings-per-share from continuing operations were 71 cents, above the FactSet consensus of 59 cents. Revenue declined to $745.5 million from $786.9 million in the year-earlier period, above the FactSet consensus of $694.9 million. The latest results reflect Endo's voluntary market withdrawal of the opioid pain medication Opana ER (notably, at the Food and Drug Administration's request), the company said, along with other factors like competitive pressures and discontinuations of U.S. generic drugs. Growth in the quarter, meanwhile, came from the company's launch of the antibiotic ertapenem for injection, an authorized generic for the brand-name of the antibiotic, Merck's Invanz, and continued growth in its U.S. brand-name sterile injectables products. Endo now expects 2018 revenue of $2.87 billion to $2.92 billion, above the FactSet consensus of $2.81 billion, and adjusted EPS from continuing operations of between $2.65 and $2.75, above the FactSet consensus of $2.60. Company shares have declined 1.2% over the last three months, compared with a 1.5% decline in the S&P 500 and a 2.3% rise in the Dow Jones Industrial Average .

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Endo?

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Endo International shares fall 8 percent on report of 'shocking' data on opioid distributionEndo International shares slid 8 percent as a '60 Minutes' report on data collected by opioid distributors regarding the amounts and destinations of painkillers is set to air Sunday.
Source: CNBC - 🏆 12. / 72 Read more »

Salesforce stock rises after hours following earnings beat
Source: MarketWatch - 🏆 3. / 97 Read more »

Stitch Fix stock rises after earnings beat
Source: MarketWatch - 🏆 3. / 97 Read more »

Dow: Stocks are poised to rise after jobs report beats expectationsStocks are poised to open higher on Friday, buoyed by an agreement that the U.S. and China will restart trade talks next week. Haha haha haha! It's going to hell, y'all. Brace yourselves for a Great Depression level crash! After dropping over 600 points at Thur. closing, lets see how today closes with Repubs keeping Govt shutdown going.
Source: USATODAY - 🏆 100. / 63 Read more »

U.S. Stocks Rise to End Turbulent 2018U.S. stocks bounced higher, attempting to chip away at some of their losses for the year, as investors eyed signs of progress in trade negotiations between the U.S. and China. Trump lies and the Dow reacts. Year to remember
Source: WSJ - 🏆 98. / 63 Read more »

Stocks rise in final session of 2018 but log biggest annual decline in 10 yearsThe winning is amazing
Source: MarketWatch - 🏆 3. / 97 Read more »

Australian stocks rise in morning trade as 2018 winds downU.S. President Donald Trump said in a tweet over the weekend that he had a 'long and very good call' with Chinese President Xi Jinping, touting 'big progress' in the deal making process between the two countries. EXCESSIVENESS ANNOYING YOU THAT'S THE IDEA STRONG BOW CIDER VERY POPULAR BACK IN 2012 The sun also rises in the morning.
Source: CNBC - 🏆 12. / 72 Read more »

Apple pops on earnings beat, strong guidanceApple's new approach to its flagship phone has made it harder than usual to gauge the company's success. 🤔 What is this? Your are tweeting old news Unfollowed
Source: CNBC - 🏆 12. / 72 Read more »

Eli Lilly beats earnings expectations, raises guidance
Source: MarketWatch - 🏆 3. / 97 Read more »